Filtering

Page: () 1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 43 ()
ECCO'17 BarcelonaDOP013: Definition of therapeutic response criteria using MRI in Crohn’s Disease patients treated with anti-TNF therapy: A multicenter prospective study (the IRMA study)
Year: 2017
Source: ECCO'17 Barcelona
Authors: Buisson A.
Crohn's disease, Disease activity Indices, MRI, Adalimumab, Infliximab
Files: 1
ECCO'18 ViennaDOP014: Impact of genetic variation on gene and protein expression in Crohn’s Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Hart Amy
Files: 1
ECCO'16 DOPDOP014: Nutritional optimisation of pre-surgical Crohn’s disease patients with enteral nutrition significantly decreases length of stay and need for a stoma
Year: 2016
Source: ECCO'16 DOP
Authors: Patel K.
ileocecal resection, postoperative complications, preoperative management, enteral nutrition
Files: 1
ECCO'17 BarcelonaDOP014: Transmural healing is better than mucosal healing in Crohn's Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Raimundo Fernandes S.
Natural history, Colonoscopy, MRI
Files: 1
ECCO'18 ViennaDOP015: Dysregulation of cell-type specific long ncRNA in the ileum of treatment naïve early onset Crohn Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Haberman Yael
Files: 1
ECCO'17 BarcelonaDOP015: International differences in gastroenterologists’ perspective on stopping therapy for patients with Crohn’s Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Siegel C.
Anti-TNF agents, Corticosteriods, Patient choice, Thiopurines (AZA / MP)
Files: 1
ECCO'16 DOPDOP015: Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn’s disease
Year: 2016
Source: ECCO'16 DOP
Authors: Buisson A.
Crohn's Disease, ileo caecal resection, post operative complications, histology
Files: 1
ECCO'16 DOPDOP017: Colectomy Free Survival is Independent of Initial Infliximab Dosing Strategy in Hospitalised Ulcerative Colitis Patients
Year: 2016
Source: ECCO'16 DOP
Authors: Shah S.
Ulcerative Colitis, infliximab, colectomy
Files: 1
ECCO'18 ViennaDOP017: Increased intestinal aryl hydrocarbon receptor expression and pathway sensitivity in Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Harrow Paul
Files: 1
ECCO'17 BarcelonaDOP017: Patterns of anti-TNF use and associated treatment outcomes in Inflammatory Bowel Disease patients: Results from an analysis of Dutch health insurance claims data
Year: 2017
Source: ECCO'17 Barcelona
Authors: Bots S.
Health economic analysis, Adalimumab, Anti-TNF agents, Infliximab
Files: 1
ECCO'17 BarcelonaDOP018: Effect of adalimumab on extraintestinal manifestations among patients with Ulcerative Colitis in a clinical practice setting: Results from INSPIRADA
Year: 2017
Source: ECCO'17 Barcelona
Authors: Skup M.
Adalimumab, Arthralgia, Pyoderma gangrenosum, Other extraintestinal manifestations
Files: 1
ECCO'17 BarcelonaDOP019: Effect of vedolizumab treatment on extraintestinal manifestations in patients with Crohn’s Disease: A GEMINI 2 post hoc analysis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Crohn's disease, Vedolizumab, Other extraintestinal manifestations
Files: 1
ECCO'16 DOPDOP019: Efficacy of Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
Year: 2016
Source: ECCO'16 DOP
Authors: Ricart E.
stem cell transplantation/therapy, Crohn's Disease
Files: 1
Page: () 1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 43 ()